We are live on ! Find out more
PPH icon

VanEck Pharmaceutical ETF
PPH

142 hedge funds and large institutions have $545M invested in VanEck Pharmaceutical ETF in 2024 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 52 increasing their positions, 46 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

72% more call options, than puts

Call options by funds: $1.2M | Put options by funds: $694K

23% more capital invested

Capital invested by funds: $442M → $545M (+$103M)

13% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 46

12% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 17

1.75% more ownership

Funds ownership: 73.85% → 75.6% (+1.7%)

1% more funds holding

Funds holding: 140 → 142 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
142
Holders Change
+2
Holders Change %
+1.43%
% of All Funds
2.04%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
19
Increased
52
Reduced
46
Closed
17
Calls
$1.2M
Puts
$694K
Net Calls
+$503K
Net Calls Change
+$3.56M

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$61.7M
2
MTWSIF
Mivtachim The Workers Social Insurance Fund
Israel
+$8.74M
3
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
+$8M
4
AWC
Adamsbrown Wealth Consultants
Kansas
+$7.03M
5
Citadel Advisors
Citadel Advisors
Florida
+$6.11M

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$13.9M
2
BC
Bricktown Capital
Michigan
-$5.9M
3
SA
Sanctuary Advisors
Indiana
-$3.96M
4
PAG
Private Advisory Group
Washington
-$3.07M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$2.41M
Name Holding Trade Value Shares
Change 		Change in
Stake
AWMT
26
AAFMAA Wealth Management & Trust
North Carolina
$3.36M +$2.04M +21,482 +155%
VAS
27
Valicenti Advisory Services
New York
$3.33M -$6.17K -65 -0.2%
BCI
28
Brinker Capital Investments
Pennsylvania
$2.93M -$94.1K -991 -3%
OPS
29
Orion Portfolio Solutions
Nebraska
$2.93M -$94.1K -991 -3%
LFAS
30
Level Four Advisory Services
Texas
$2.82M -$834K -8,778 -22%
TRCT
31
Tower Research Capital (TRC)
New York
$2.78M +$2.78M +29,238 New
AWM
32
Apollon Wealth Management
South Carolina
$2.72M +$89.8K +946 +3%
Susquehanna International Group
33
Susquehanna International Group
Pennsylvania
$2.71M -$2.41M -25,402 -47%
Ameriprise
34
Ameriprise
Minnesota
$2.55M +$232K +2,446 +10%
AGC
35
Aspen Grove Capital
Colorado
$2.42M +$9.5K +100 +0.4%
D.E. Shaw & Co
36
D.E. Shaw & Co
New York
$2.33M +$967K +10,180 +71%
EH
37
Equitable Holdings
New York
$2.3M +$211K +2,221 +10%
CIBC World Market
38
CIBC World Market
Ontario, Canada
$2.2M +$151K +1,585 +7%
Osaic Holdings
39
Osaic Holdings
Arizona
$2.16M -$188K -1,979 -8%
BCM
40
Beck Capital Management
Texas
$2.13M +$105K +1,109 +5%
SIM
41
Seaview Investment Managers
Florida
$2.11M +$2.11M +22,240 New
Bank of Montreal
42
Bank of Montreal
Ontario, Canada
$2.05M +$624K +6,570 +44%
Jane Street
43
Jane Street
New York
$1.85M +$1.02M +10,759 +124%
Renaissance Technologies
44
Renaissance Technologies
New York
$1.84M -$617K -6,500 -25%
Commonwealth Equity Services
45
Commonwealth Equity Services
Massachusetts
$1.65M -$161K -1,691 -9%
RJFSA
46
Raymond James Financial Services Advisors
Florida
$1.64M -$109K -1,146 -6%
UBS Group
47
UBS Group
Switzerland
$1.61M +$175K +1,840 +12%
National Bank of Canada
48
National Bank of Canada
Quebec, Canada
$1.3M -$9.5K -100 -0.7%
OC
49
Oppenheimer & Co
New York
$1.28M +$94K +990 +8%
SWA
50
Stratos Wealth Advisors
Ohio
$1.24M +$359K +3,778 +41%
1
2
3 4 5

PPH Hedge Fund Activity: Q3 2024 in Review

142 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in VanEck Pharmaceutical ETF (PPH) for Q3 2024, worth a combined $545M — up 23% from $442M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new PPH positions and 17 closed out — a net gain of 2 holders — while 52 added to existing stakes and 46 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $61.7M. The largest seller was JP Morgan Chase, cutting an estimated $13.9M.

  • 142 institutional investors held VanEck Pharmaceutical ETF (PPH) as of Q3 2024, up from 140 in Q2 2024.
  • Funds reported $545M of VanEck Pharmaceutical ETF stock for Q3 2024, up 23% quarter-over-quarter.
  • 19 funds opened new VanEck Pharmaceutical ETF positions in Q3 2024 and 17 closed out, a net change of +2 holders.
  • The largest VanEck Pharmaceutical ETF buyer in Q3 2024 was Goldman Sachs, an estimated $61.7M added.
  • The largest VanEck Pharmaceutical ETF seller in Q3 2024 was JP Morgan Chase, an estimated $13.9M sold.

Based on aggregated 13F filings for Q3 2024.